60
Participants
Start Date
February 29, 2008
Primary Completion Date
May 31, 2009
Study Completion Date
June 30, 2009
Avelox (Moxifloxacin, BAY12-8039)
IV therapy: every 24 hours, patients will be administered a 400 mg moxifloxacin infusion over 60 minutes. Oral therapy: patients will be administered a single moxifloxacin 400 mg tablet, every 24 hours
Ceftriaxone; Azithromycin; Amoxicilline/clavulanate; Clarithromycin
IV therapy: every 24 hours patients will be administered a 2 g ceftriaxone infusion over 30 minutes. Following the infusion with ceftriaxone, patients will be administered a 500 mg azithromycin infusion over 180 minutes.Oral therapy: every 8 hours patients will be administered a 1000 mg amoxicillin/clavulanic acid tablet. Every 12 hours patients will be administered a 500 mg clarithromycin tablet.
Torino
Milan
Milan
Brescia
Vittorio Veneto
Udine
Lucca
Fossombrone
Macerata
Ascoli Piceno
Chieti
Foggia
San Cesario di Lecce
Benevento
Pregiato Di Cava Dei Tirreni
Lungro
Palermo
Catania
Messina
Roma
Roma
Roma
Sassari
Lead Sponsor
Bayer
INDUSTRY